Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

Access & Diagnostic products

Precise and selective solutions to access lesions

Products

 

 

Safety and efficacy of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinomahttps://www.terumo-europe.com/en-emea/clinical-program/Pages/Safety-and-efficacy-of-balloon‐occluded-transcatheter-arterial-chemoembolization-using-miriplatin-for-hepatocellular-carcin.aspxSafety and efficacy of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma<p>​Hirotaka Arai et al Gunma University Graduate School of Medicine, Maebashi, Japan</p>HayabusaArticlePage
Safety and efficacy of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinomahttps://www.terumo-europe.com/en-emea/clinicaldata/safety-and-efficacy-of-balloon‐occluded-transcatheter-arterial-chemoembolization-using-miriplatin-for-hepatocellular-carcinomaSafety and efficacy of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma<p>​Hirotaka Arai et al Gunma University Graduate School of Medicine, Maebashi, Japan</p>HayabusaArticlePage